このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation in Early-Stage Cancer Patients

2026年9月17日 更新者:Wei XIA, PhD、Sun Yat-sen University

Construction and Effectiveness of a Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation Among Early-Stage Cancer Patients

The goal of this clinical trial is to evaluate the effectiveness of a Multi-Theory Model (MTM)-based AI agent intervention for smoking cessation in early-stage cancer patients (clinical stage cTNM 0~II) who currently smoke. The main questions it aims to answer are:

Does the AI agent intervention improve the biochemically verified 7-day point prevalence abstinence rate at the 6-month follow-up compared to control groups?

Is the AI agent intervention feasible and acceptable for early-stage cancer patients?

Researchers will compare the AI agent intervention group to an professional counseling group and a routine health education groupto see if the AI agent yields higher smoking cessation rates and better maintenance of abstinence.

Participants will:

Be randomly assigned to one of three groups to receive either AI agent support via WeChat, professional counseling via Phone, or routine health education.

Interact with the AI agent (if in the intervention group) which provides personalized guidance, emotional support, and resource matching based on the Multi-Theory Model constructs (e.g., participatory dialogue, emotional transformation).

Complete questionnaires regarding smoking behavior, nicotine dependence, self-efficacy, and quality of life at baseline and follow-ups (1 week, 1 month, 3 months, and 6 months).

Provide exhaled carbon monoxide (CO) and saliva cotinine samples for biochemical verification if they report successful smoking cessation.

調査の概要

研究の種類

介入

入学 (推定)

156

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  1. Age ≥18 years, diagnosed with early-stage cancer (AJCC 8th edition clinical stage cTNM 0-II);
  2. Smoked in the past 30 days, with an average daily consumption of > 1 cigarette, and an exhaled Carbon Monoxide (CO) level ≥ 4 ppm;
  3. Able to communicate using WeChat;
  4. Able to understand and read Chinese, and possess conversational Mandarin skills;
  5. Willing to participate in this study and sign the informed consent form.

Exclusion Criteria:

  1. Individuals who are unable to communicate due to severe mental or physical illness;
  2. Individuals currently participating in other tobacco control research projects;
  3. Individuals whose cancer has metastasized.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:AI Agent Intervention Group

Participants in this group will access a customized "Smoking Cessation AI Agent" via the WeChat platform. The agent utilizes a Large Language Model with Retrieval-Augmented Generation (RAG) to provide professional, evidence-based support grounded in the Multi-Theory Model (MTM).

Key features include:

24/7 Personalized Interaction: Offers open-ended dialogue, personalized advice, and proactive pushes (e.g., health education cards, check-in incentives).

Stage-Matched Guidance:

Initiation Phase: Focuses on participatory dialogue to weigh pros/cons and behavioral confidence building through goal setting.

Maintenance Phase: Focuses on emotional transformation (managing withdrawal/emotions), practice for change, and modifying the social/physical environment (e.g., matching cessation resources, peer support).

Dynamic Adaptation: The agent dynamically adjusts its strategies based on the user's interaction frequency and quitting progress.

An AI agent powered by a Large Language Model with Retrieval-Augmented Generation (RAG). It provides 24/7 personalized smoking cessation support based on the Multi-Theory Model (MTM).

Key Functions:

Initiation Phase: Participatory dialogue to weigh pros/cons and goal setting to build behavioral confidence.

Maintenance Phase: Emotional transformation support, habit tracking (practice for change), and social/physical environment resource matching (e.g., peer support).

Dynamic Adaptation: Adjusts content and push frequency based on user interaction and quitting stage.

アクティブコンパレータ:Counseling Group

Participants in this group receive smoking cessation counseling by WeChat from specialists.

Proactive Intervention: Specialists contact participants twice a month.

Content: Brief counseling (approx. 30 seconds to 5 minutes) based on WHO guidelines, including assessing smoking status, difficulties, and progress, and providing customized advice (e.g., motivation boosting, coping strategies for withdrawal).

Reactive Support: Participants can proactively contact the specialists during working hours (Mon-Fri, 8:00-17:00) for inquiries.

WeChat-based counseling provided by smoking cessation specialists twice a month, following WHO guidelines.
介入なし:Health Education Group

Participants receive standard care only, which consists of routine brief smoking cessation advice from physicians during their regular hospital visits.

This group does not receive any additional active intervention, education, or follow-up counseling from the research team, except for data collection at scheduled follow-up points (baseline, 1 week, 1 month, 3 months, and 6 months).

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Biochemically validated 7-Day Point Prevalence Abstinence Rate
時間枠:6 month follow-up after randomization
Participants are considered abstinent if they self-report having smoked 0 cigarettes (not even a puff) in the past 7 days, confirmed by a biochemical validation of exhaled Carbon Monoxide (CO) concentration < 4 ppm and saliva cotinine concentration < 115 ng/ml
6 month follow-up after randomization

二次結果の測定

結果測定
メジャーの説明
時間枠
Self-Reported 7-Day Point Prevalence Abstinence Rate
時間枠:1 week, 1 month, 3 months, and 6-month follow-up
The proportion of participants who self-report having smoked no cigarettes in the past 7 days, without biochemical verification at interim time points.
1 week, 1 month, 3 months, and 6-month follow-up
Smoking Reduction Rate
時間枠:1 week, 1 month, 3 months, and 6-month follow-up
Defined as a reduction in daily cigarette consumption by ≥50% compared to baseline levels.
1 week, 1 month, 3 months, and 6-month follow-up
Change in Smoking Self-Efficacy
時間枠:Baseline, 1 week, 1 month, 3 months, and 6-months follow-up
Measured using the Smoking Self-Efficacy Questionnaire (SEQ-12). The scale contains 12 items rated on a 5-point Likert scale. Total scores range from 12 to 60, with higher scores indicating greater confidence in the ability to refrain from smoking in various situations.
Baseline, 1 week, 1 month, 3 months, and 6-months follow-up
Change in Quality of Life
時間枠:Baseline,1 week, 1 month, 3 months, and 6-months follow-up
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Responses will be converted to an EQ-5D-5L index score using the prespecified value set, with higher scores indicating better health-related quality of life. The outcome will be reported as the change in EQ-5D-5L index score from baseline.
Baseline,1 week, 1 month, 3 months, and 6-months follow-up
Total Duration of AI Agent Use
時間枠:From randomization through 6 months
AI agent use will be assessed using automatically recorded backend system logs. The cumulative duration of AI agent use for each participant during the follow-up period will be calculated. The unit of measure is minutes.
From randomization through 6 months
Mean AI Agent Response Time
時間枠:From randomization through 6 months
Mean AI agent response time will be calculated using backend system timestamps as the average time between submission of a participant message and generation of the corresponding AI agent response. The unit of measure is seconds.
From randomization through 6 months
Mean AI Agent Session Duration
時間枠:From randomization through 6 months
Mean session duration will be calculated from backend system logs as the total duration of AI agent use divided by the number of usage sessions for each participant. The unit of measure is minutes per session.
From randomization through 6 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年10月1日

一次修了 (推定)

2027年8月1日

研究の完了 (推定)

2027年8月31日

試験登録日

最初に提出

2026年7月28日

QC基準を満たした最初の提出物

2026年9月17日

最初の投稿 (実際)

2026年9月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月18日

QC基準を満たした最後の更新が送信されました

2026年9月17日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

The data will be shared one year after the results of the study'are published. The researchers can access the data by contacting the PI at xiaw23@mail.sysu.edu.cn with the research purpose described.

IPD 共有時間枠

One year after the results of the study are published

IPD 共有アクセス基準

The researchers can access the data by contacting the PI at xiaw23@mail.sysu.edu.cn with the research purpose described.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する